Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80

News > All

Total search results: 11766 | Ordered by Date (descending)
1 2 3 ... 116 117 118  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
SR One Capital Management. (11/19/20). "Press Release: SR One Completes Spin-out from GSK and Closes First Fund at $500 Million". San Francisco, CA & London. 2020-11-19
ipOcean Global GmbH. (11/19/20). "Press Release: Losan Pharma Starts the First Online Innovation Circle on »Nanoliposomes for oral delivery of peptides and macromolecules« to Overcome Social Distancing Caused by Corona". Mainz. 2020-11-19
SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin. 2020-11-19
Rebus Biosystems, Inc.. (11/19/20). "Press Release: Rebus Biosystems, Inc. Announces $20 Million Series B Financing to Support Commercialization of Automated Spatial Omics Solution". Santa Clara, CA. 2020-11-19
Umoja Biopharma, Inc.. (11/18/20). "Press Release: Umoja Biopharma Launches with $53M Series A Financing to Develop Fully Integrated, Scalable, In Vivo Immunotherapy Platform". Seattle, WA. 2020-11-18
Pharvaris B.V.. (11/18/20). "Press Release: Pharvaris Announces $80 Million Series C Financing to Advance Novel Oral Bradykinin-B2-Receptor Antagonists for the Treatment of HAE". Zug. 2020-11-18
Apple Tree Partners. (11/16/20). "Press Release: Nereid Therapeutics Launches. ATP $50M Series A NewCo Co-Founded with Brangwynne, Pioneer of Biomolecular Condensates Field". Boston, MA. 2020-11-16
64x Bio. (11/16/20). "Press Release: 64x Bio Emerges from Stealth to Drive an Evolution in Cell and Gene Therapy Manufacturing". San Francisco, CA. 2020-11-16
Jeito Capital. (11/13/20). "Press Release: Sanofi Selects Jeito Capital as Its First Investment into a Private French-based Fund". Paris. 2020-11-13
Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen. 2020-11-12
[iito] Business Intelligence. (11/12/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. 2020-11-12
Beckman Coulter Life Sciences. (11/12/20). "Press Release: Beckman Coulter Life Sciences Acquires Microbioreactor Manufacturer m2p-labs". Indianapolis, IN. 2020-11-12
UCB S.A.. (11/12/20). "Press Release: UCB Strengthens Its Gene Therapy Activities with Additional Pipeline Programs, Capabilities and Platforms". Brussels. 2020-11-12
BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz. 2020-11-11
MorphoSys AG. (11/11/20). "Press Release: Xencor, MorphoSys and Incyte Enter into Global Development Collaboration for Tafasitamab in Combination with Plamotamab". Monrovia, CA, Planegg & Wilmington, DE. 2020-11-11
[iito] Business Intelligence. (11/10/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. 2020-11-10
Consilium Strategic Communications Ltd.. (11/10/20). "Press Release: Consilium Strategic Communications Strengthens Global Team in the US and Europe". London. 2020-11-10
Cevec Pharmaceuticals GmbH. (11/10/20). "Press Release: Cevec Signs Agreement with Roche for the Use of Cevec’s Elevecta Technology in Gene Therapy". Cologne. 2020-11-10
Valneva S.E.. (11/10/20). "Press Release: Valneva Announces Plans for Extraordinary General Meeting to Prepare for Potential US IPO". Saint-Herblain. 2020-11-10
Merck KGaA. (11/9/20). "Press Release: Merck Announces Out-licensing Agreement for Investigational Atacicept with Vera Therapeutics [Not intended for UK and US based media]". Darmstadt. 2020-11-09
Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin. 2020-11-09
Kurma Partners. (11/9/20). "Press Release: Kurma Partners Strengthens Its Teams and Promotes Its Talents". Paris. 2020-11-09
BioNTech SE. (11/9/20). "Press Release: Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study". New York, NY & Mainz. 2020-11-09
Novo Holdings A/S. (11/9/20). "Press Release: Novo Ventures-incubated Rare Disease Company, Stargazer Pharmaceuticals, Enters Ph2 Development and Announces $57m Series A Financing". Boston, MA. 2020-11-09
Vifor Pharma AG. (11/09/20). "Press Release: Vifor Pharma and Angion Sign License Agreement for ANG-3777 in Nephrology Indications". St. Gallen & Uniondale, NY. 2020-11-09
[iito] Business Intelligence. (11/8/20). "The [LSUS] Newsletter Is Out! Hand-picked & Manually Edited Transatlantic Life Science Business News from Europe and North America". Bremen. 2020-11-08
PledPharma AB. (11/6/20). "Press Release: Henrik Krook Appointed VP Commercial Operations at PledPharma". Stockholm. 2020-11-06
Emisphere Technologies, Inc.. (11/6/20). "Press Release: Novo Nordisk to Acquire Emisphere Technologies for $1.35 Billion". Roseland, NJ. 2020-11-06
Huntsworth. (11/6/20). "Press Release: Huntsworth Expands Global Health Network with Nucleus Acquisition". London. 2020-11-06
Coulter Partners. (11/5/20). "Press Release: Coulter Partners Announces New Appointments in the US, London and Denmark". 2020-11-05
Cytek Biosciences Inc.. (11/5/20). "Press Release: Cytek Biosciences Completes Series D Funding Round". Fremont, CA. 2020-11-05
Arix Bioscience plc. (11/5/20). "Press Release: VelosBio to Be Acquired by Merck for $2.75 Billion". London. 2020-11-05
Sofie Biosciences, Inc.. (11/4/20). "Press Release: Sofie Biosciences Inc. (SOFIE) Concludes $27.4m Series C Financing". Dulles, VA. 2020-11-04
PerkinElmer, Inc.. (11/2/20). "Press Release: PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)". Waltham, MA. 2020-11-02
Oxford BioDynamics plc. (11/2/20). "Press Release: Oxford BioDynamics Announces Strategic Partnership with Boca Biolistics in Order to Advance EpiSwitch Disease Severity Program for COVID-19". Oxford. 2020-11-02
Fountain Healthcare Partners. (11/2/20). "Press Release: Fountain Healthcare Partners Announces Final Close of €125 Million for Fund III". 2020-11-02
Corlieve Therapeutics S.A.S.. (11/2/20). "Press Release: Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions". Paris. 2020-11-02
Kiadis Pharma N.V.. (11/2/20). "Press Release: Sanofi Offers to Acquire Kiadis for €308 Million". Paris & Amsterdam. 2020-11-02
EuropaBio. (11/2/20). "Press Release: EuropaBio Announces Dr Claire Skentelbery as New Director General of the Association". Brussels. 2020-11-02
Definitive Healthcare, LLC. (10/29/20). "Press Release: Definitive Healthcare Expands into Medical and Scientific Identification with Acquisition of Monocl". Framingham, MA. 2020-10-29
Vedere Bio, Inc.. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, a Novel Optogenetics AAV Gene Therapy Company". Cambridge, MA. 2020-10-29
Novartis AG. (10/29/20). "Press Release: Novartis Acquires Vedere Bio, Adding Novel Optogenetic Gene Therapy Technology for Treating Blindness". Basel. 2020-10-29
EBD Group. (10/28/20). "Press Release: BIO-Europe Digital Startup Slam Winner 2020 – KyNexis Medicine Development". Munich. 2020-10-28
CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA. 2020-10-28
Gracell Biotechnologies Inc.. (10/28/20). "Press Release: Gracell Biotechnologies Raises $100 Million in Series C Funding to Advance Next Generation CAR-T Cell Therapies". Suzhou & Shanghai. 2020-10-28
Galecto, Inc.. (10/28/20). "Press Release: Galecto Announces Pricing of Initial Public Offering". Boston, MA & Copenhagen. 2020-10-28
Scope Fluidics S.A.. (10/28/20). "Press Release: Prof. Carl Wittwer – the Legendary Creator of the PCR Technology – Joins the Scope Fluidics Advisory Committee". Warsaw. 2020-10-28
Prokarium Ltd.. (10/27/20). "Press Release: Prokarium Closes $21M Series B Financing Round and Strengthens Board". London. 2020-10-27
Eagle Genomics Ltd.. (10/27/20). "Press Release: Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend". Cambridge. 2020-10-27
Thrive Earlier Detection Corporation. (10/27/20). "Press Release: Exact Sciences to Acquire Thrive Earlier Detection, Becoming a Leader in Blood-Based, Multi-Cancer Screening". Madison, WI & Cambridge, MA. 2020-10-27
Ogilvy. (10/27/20). "Press Release: Ogilvy Appoints Kate Cronin to Global Role as CEO of Ogilvy Health". New York, NY. 2020-10-27
TVM Capital Life Science. (10/27/20). "Press Release: TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, Largest Fund in the Firm’s History ". Munich & Montreal. 2020-10-27
NBE Therapeutics AG. (10/26/20). "Press Release: NBE-Therapeutics Commences First Clinical Study of Anti-ROR1 Antibody-Drug Conjugate for Patients with Solid Tumors". Basel. 2020-10-26
Bayer AG. (10/26/20). "Press Release: Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy". Berlin. 2020-10-26
MLM Medical Labs GmbH. (10/26/20). "Press Release: MLM Medical Labs Continues International Growth with Addition of MD Biosciences in the United States". 2020-10-26
Scorpion Therapeutics, Inc.. (10/26/20). "Press Release: Scorpion Therapeutics Launches with $108 Million to Advance Precision Oncology 2.0". Boston, MA. 2020-10-26
Eternygen GmbH. (10/26/20). "Press Release: Eternygen Announces the First Closing of its Series A2 Funding Round". Berlin. 2020-10-26
Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. 2020-10-23
Atea Pharmaceuticals, Inc.. (10/22/20). "Press Release: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19". Boston, MA. 2020-10-22
SparingVision. (10/21/20). "Press Release: SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive Officer". Paris. 2020-10-21
Vifor Pharma AG. (10/20/20). "Press Release: Vifor Pharma and Cara Therapeutics Sign US License Agreement for i.v. Korsuva to Treat Dialysis Patients with Pruritus". St. Gallen & Stamford, CT. 2020-10-20
Selexis S.A.. (10/20/20). "Press Release: JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities for Selexis and KBI Biopharma in Geneva, Switzerland". Sunnyvale, CA. 2020-10-20
Proteintech Group, Inc.. (10/20/20). "Press Release: Proteintech Acquires ChromoTek, Expanding its Next Generation Antibody Tools". Chicago, IL & Munich. 2020-10-20
Immunic, Inc.. (10/20/20). "Press Release: EIB Provides Immunic With up to €24.5 Million to Support Ongoing Development of a Potential COVID-19 Therapy". Luxembourg, Gräfeling & New York, NY. 2020-10-20
Precigen, Inc.. (10/20/20). "Press Release: Precigen Strengthens Focus on Strategic Partnerships and Names Gaurav Vij Head of Business Development". Germantown, MD. 2020-10-20
Centogene N.V.. (10/20/20). "Press Release: Centogene Announces Leadership Transition". Cambridge, MA & Rostock. 2020-10-20
Atbtherapeutics. (10/20/20). "Press Release: Atbtherapeutics Strengthens Its Scientific Advisory Board to Support the Development of its Novel Platform and Portfolio". Belgium. 2020-10-20
ProteoNic B.V.. (10/20/20). "Press Release: ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics". Leiden. 2020-10-20
Cevec Pharmaceuticals GmbH. (10/19/20). "Press Release: Cevec and Rznomics Sign License Agreement for the Use of CAP® Technology in Manufacturing of Adenoviral Vectors". 2020-10-19
BioSpecifics Technologies Corporation. (10/19/20). "Press Release: BioSpecifics to be Acquired by Endo Pharmaceuticals". Wilmington, DE. 2020-10-19
Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried. 2020-10-19
Topas Therapeutics GmbH. (10/19/20). "Press Release: Topas Therapeutics Appoints Klaus Martin, Ph.D. as Chief Executive Officer". Hamburg. 2020-10-19
Selexis S.A.. (10/16/20). "Press Release: Selexis Names Biopharmaceutical Executive Dirk Lange as New Chief Executive Officer". Geneva. 2020-10-16
Promethean Particles Ltd.. (10/16/20). "Press Release: Promethean Particles Appoints New CEO to Lead Accelerated Commercialisation". 2020-10-16
VectivBio AG. (10/15/20). "Press Release: VectivBio Closes $110 Million Crossover Financing to Advance Transformational Medicines for Rare Diseases". Basel. 2020-10-15
Galapagos N.V.. (10/15/20). "Press Release: Galapagos and Servier Report Topline Results for ROCCELLA Phase 2 Clinical Trial with GLPG1972/S201086 in Knee Osteoarthritis Patients". Mechelen & Paris. 2020-10-15
Astellas Pharma Inc.. (10/15/20). "Press Release: Astellas to Acquire Iota Biosciences". Tokyo & Berkeley, CA. 2020-10-15
Consilium Strategic Communications Ltd.. (10/15/20). "Press Release: Consilium Strategic Communications Advises Compass Pathways on Its Successful Initial Public Offering". London. 2020-10-15
Precigen, Inc.. (10/15/20). "Press Release: Precigen’s UltraPorator Receives FDA Clearance for Manufacturing UltraCAR-T Cells in Clinical Trials". Germantown, MD. 2020-10-15
Bayer AG. (10/15/20). "Press Release: Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra". Leverkusen & Branford, CT. 2020-10-15
Oncopeptides AB. (10/14/20). "Press Release: Oncopeptides Signs € 40 Million Loan Agreement with the EIB". Stockholm. 2020-10-14
RayzeBio, Inc.. (10/14/20). "Press Release: RayzeBio Launches with $45 Million Series A to Advance Portfolio of Targeted Radiopharmaceuticals for Cancer Therapeutics". San Diego, CA. 2020-10-14
Rentschler Biopharma SE. (10/14/20). "Press Release: Rentschler Biopharma and ATUM Announce Leap-In Transposase Licensing Agreement for Development of Robust Manufacturing Processes for Complex Therapeutic Proteins". Laupheim, Milford, MA & Newark, CA. 2020-10-14
Johnson & Johnson. (10/14/20). "Press Release: Janssen Japan President Chris Hourigan Named New Company Group Chairman for Janssen Asia Pacific". Singapore. 2020-10-14
Ori Biotech Ltd.. (10/14/20). "Press Release: Ori Biotech Raises $30 Million in Series A Financing to Advance Innovation in Cell and Gene Therapy Manufacturing". London & Woodcliff Lake, NJ. 2020-10-14
Polyphor Ltd.. (10/14/20). "Press Release: Polyphor Receives CARB-X Award of up to USD 18.44 Million to Support Development of New Antibiotic Program". Allschwil. 2020-10-14
Twist Bioscience Corporation. (10/13/20). "Press Release: Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies". South San Francisco, CA, Amsterdam & New York, NY. 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: Ad hoc – MorphoSys AG Launches an Offering of approx. EUR 325 Million Convertible Bonds". Planegg. 2020-10-13
Chord Therapeutics S.A.. (10/13/20). "Press Release: Chord Therapeutics Launches with USD 16 Million Series A Financing from Omega Funds". 2020-10-13
MorphoSys AG. (10/13/20). "Press Release: MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds [Not for US, AU, ZA, JP, et al.]". Planegg. 2020-10-13
Oxurion N.V.. (10/13/20). "Press Release: Oxurion NV Appoints Tom Graney, CFA as Chief Financial Officer". Leuven & Boston, MA. 2020-10-13
Rappta Therapeutics Oy. (10/13/20). "Press Release: Rappta Therapeutics Raises Series A Financing for the Development of Phosphatase 2A Drugs". Helsinki. 2020-10-13
Qiagen N.V.. (10/13/20). "Press Release: Qiagen Reports Strong Preliminary Results for Third Quarter of 2020". Venlo. 2020-10-13
Axol Bioscience Ltd.. (10/13/20). "Press Release: Axol Bioscience Introduces Multi-electrode Array Screening Services for Human iPSC-derived Cells". Cambridge. 2020-10-13
Evotec SE. (10/13/20). "Press Release: Mubdala Investment Company and Novo Holdings A/S Invest €250m in Evotec SE". Hamburg. 2020-10-13
Priothera Ltd.. (10/12/20). "Press Release: Priothera Closes €30 Million Series A Financing to Develop Highly Promising Therapies for Acute Myeloid Leukemia (AML)". Dublin. 2020-10-12
Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt. 2020-10-12
Precigen, Inc.. (10/9/20). "Press Release: Precigen Announces Merck KGaA, Darmstadt, Germany Increases Ownership Position Through Exercise of Convertible Note". Germantown, MD. 2020-10-09
1 2 3 ... 116 117 118  next pagenext page



Advertisement

Picture [iito] No Content Marketing 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top